256 related articles for article (PubMed ID: 19108834)
1. Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages.
Okutsu R; Yoshikawa T; Nagasawa M; Hirose Y; Takase H; Mitani K; Okada K; Miyakoda G; Yabuuchi Y
Atherosclerosis; 2009 Jun; 204(2):405-11. PubMed ID: 19108834
[TBL] [Abstract][Full Text] [Related]
2. PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
Lin CS; Lin FY; Ho LJ; Tsai CS; Cheng SM; Wu WL; Huang CY; Lian CH; Yang SP; Lai JH
Cardiovasc Res; 2012 Aug; 95(3):346-55. PubMed ID: 22687273
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
[TBL] [Abstract][Full Text] [Related]
4. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW
J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060
[TBL] [Abstract][Full Text] [Related]
5. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.
Chellan B; Reardon CA; Getz GS; Hofmann Bowman MA
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1101-13. PubMed ID: 27079883
[TBL] [Abstract][Full Text] [Related]
6. Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice.
Dai XY; Cai Y; Mao DD; Qi YF; Tang C; Xu Q; Zhu Y; Xu MJ; Wang X
J Mol Cell Cardiol; 2012 Oct; 53(4):509-20. PubMed ID: 22841663
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protein kinase Cbeta prevents foam cell formation by reducing scavenger receptor A expression in human macrophages.
Osto E; Kouroedov A; Mocharla P; Akhmedov A; Besler C; Rohrer L; von Eckardstein A; Iliceto S; Volpe M; Lüscher TF; Cosentino F
Circulation; 2008 Nov; 118(21):2174-82. PubMed ID: 18981301
[TBL] [Abstract][Full Text] [Related]
8. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
9. An unbiased chemical biology screen identifies agents that modulate uptake of oxidized LDL by macrophages.
Etzion Y; Hackett A; Proctor BM; Ren J; Nolan B; Ellenberger T; Muslin AJ
Circ Res; 2009 Jul; 105(2):148-57. PubMed ID: 19542016
[TBL] [Abstract][Full Text] [Related]
10. Effects of lycopene on the induction of foam cell formation by modified LDL.
Napolitano M; De Pascale C; Wheeler-Jones C; Botham KM; Bravo E
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1820-7. PubMed ID: 17911344
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.
Geng YJ; Hansson GK
J Clin Invest; 1992 Apr; 89(4):1322-30. PubMed ID: 1556191
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo.
Nakaya K; Ayaori M; Uto-Kondo H; Hisada T; Ogura M; Yakushiji E; Takiguchi S; Terao Y; Ozasa H; Sasaki M; Komatsu T; Ohsuzu F; Ikewaki K
Atherosclerosis; 2010 Nov; 213(1):135-41. PubMed ID: 20723893
[TBL] [Abstract][Full Text] [Related]
14. VEGF secretion by macrophages is stimulated by lipid and protein components of OxLDL via PI3-kinase and PKCzeta activation and is independent of OxLDL uptake.
Riazy M; Chen JH; Steinbrecher UP
Atherosclerosis; 2009 May; 204(1):47-54. PubMed ID: 18789802
[TBL] [Abstract][Full Text] [Related]
15. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.
Holvoet P; Perez G; Bernar H; Brouwers E; Vanloo B; Rosseneu M; Collen D
J Clin Invest; 1994 Jan; 93(1):89-98. PubMed ID: 8282826
[TBL] [Abstract][Full Text] [Related]
16. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
[TBL] [Abstract][Full Text] [Related]
17. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis.
Hayek T; Kaplan M; Raz A; Keidar S; Coleman R; Aviram M
Atherosclerosis; 2002 Mar; 161(1):65-74. PubMed ID: 11882318
[TBL] [Abstract][Full Text] [Related]
18. Macrophage foam-cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose.
Hayek T; Hussein K; Aviram M; Coleman R; Keidar S; Pavoltzky E; Kaplan M
Atherosclerosis; 2005 Nov; 183(1):25-33. PubMed ID: 16216589
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis.
Seike M; Ikeda M; Matsumoto M; Hamada R; Takeya M; Kodama H
J Dermatol Sci; 2006 Mar; 41(3):197-204. PubMed ID: 16356687
[TBL] [Abstract][Full Text] [Related]
20. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
